Atlas Trials

Estimation and Prediction of Individual Benefit From Postoperative Adjuvant Transcatheter Arterial Chemoembolization For Patients With Hepatocellular Carcinoma

Clinical trial NCT07562763 · COMPLETED

Trial details

NCT number
NCT07562763
Sponsor
Anhui Provincial Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Hepatocellular Carcinoma (HCC)Transarterial ChemoembolizationAdjuvant TherapyMachine LearningTreatment Effectiveness
Start date
2018-01-01
Primary completion
2025-12-31
Enrollment
1005

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.